{"file_path": "/Users/sz904/Desktop/11711/LTI_Neural_Navigator/data/2024-02-26/chunk_paper_txt/Rita_Singh_A_Gene-Based_Algorithm_for_Identifying_Factors_That_May_Affect_a_Speaker\u2019s_Voice_chunk_16.txt", "num_qa_pairs": 10, "qa_list": [{"question": " What is the title of the article mentioned in the text?", "answer": " Aggressive juvenile polyposis in children with chromosome 10q23 deletion.", "ref_chunk": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}, {"question": " In what year was the article published?", "answer": " 2013.", "ref_chunk": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}, {"question": " What clinical spectrum is associated with individuals with de novo EBF3 variants or deletions?", "answer": " Individuals with de novo EBF3 variants or deletions have a clinical spectrum that includes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.", "ref_chunk": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}, {"question": " What syndrome is caused by disruption of the PHF21A gene?", "answer": " Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.", "ref_chunk": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}, {"question": " Which syndrome is characterized by dysfunctional SHANK2 and CHRNA7 genes?", "answer": " A patient with intellectual disability and language impairment has dysfunction of SHANK2 and CHRNA7 genes.", "ref_chunk": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}, {"question": " What is the clinical and molecular characterization associated with distal 11q deletions?", "answer": " Patients with distal 11q deletions have been clinically and molecularly characterized.", "ref_chunk": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}, {"question": " What region of chromosomes is found to have a deletion in Jacobsen syndrome?", "answer": " Jacobsen syndrome is due to an unbalanced translocation between 11q23 and 22q11.2.", "ref_chunk": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}, {"question": " What is the role of the HMGA2 gene in the 12q14 microdeletion syndrome?", "answer": " The HMGA2 gene plays a role in growth in the 12q14 microdeletion syndrome.", "ref_chunk": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}, {"question": " Describe the 13q12.3 microdeletion syndrome.", "answer": " The 13q12.3 microdeletion syndrome is characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes.", "ref_chunk": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}, {"question": " What is the underlying cause of Frias syndrome?", "answer": " Haploinsufficiency of the BMP4 gene may be the underlying cause of Frias syndrome.", "ref_chunk": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}], "doc_text": "Lawson, C.E.; Cocjin, J.; Attard, T.; Ardinger, H.H. Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J. Gastroenterol. WJG 2013, 19, 2286. [CrossRef] 29. 28. 30. Nishi, E.; Uehara, T.; Yanagi, K.; Hasegawa, Y.; Ueda, K.; Kaname, T.; Yamamoto, T.; Kosaki, K.; Okamoto, N. Clinical spectrum of individuals with de novo EBF3 variants or deletions. Am. J. Med. Genet. Part A 2021, 185, 2913\u20132921. [CrossRef] 31. Kim, H.G.; Rosenfeld, J.A.; Scott, D.A.; B\u00e9n\u00e9dicte, G.; Labonne, J.D.; Brown, J.; McGuire, M.; Mahida, S.; Naidu, S.; Gutierrez, J.; et al. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Mol. Autism 2019, 10, 35. [CrossRef] 32. Xu, S.; Han, J.; Morales, A.; Menzie, C.; Williams, K.; Fan, Y.S. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet. Genome Res. 2008, 122, 181\u2013187. [CrossRef] 33. Borsel, J.V.; Morlion, B.; Snick, K.V.; Leroy, J.S. Articulation in Beckwith-Wiedemann syndrome: Two case studies. Am. J. Speech-Lang. Pathol. 2000, 9, 202\u2013213. [CrossRef] 34. Kim, Y.S.; Kim, G.H.; Byeon, J.H.; Eun, S.H.; Eun, B.L. Chromosome 11q13 deletion syndrome. Korean J. Pediatr. 2016, 59, S10. [CrossRef] 35. Chilian, B.; Abdollahpour, H.; Bierhals, T.; Haltrich, I.; Fekete, G.; Nagel, I.; Rosenberger, G.; Kutsche, K. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin. Genet. 2013, 84, 560\u2013565. [CrossRef] 36. Takahashi, I.; Takahashi, T.; Sawada, K.; Shimojima, K.; Yamamoto, T. Jacobsen syndrome due to an unbalanced translocation between 11q23 and 22q11.2 identi\ufb01ed at age 40 years. Am. J. Med. Genet. Part A 2012, 158, 220\u2013223. [CrossRef] 37. Penny, L.A.; Dell\u2019Aquila, M.; Jones, M.C.; Bergoffen, J.; Cunniff, C.; Fryns, J.P.; Grace, E.; Graham, J.M.; Kousseff, B.; Mattina, T.; et al. Clinical and molecular characterization of patients with distal 11q deletions. Am. J. Hum. Genet. 1995, 56, 676. 38. Manolakos, E.; Orru, S.; Neroutsou, R.; Kefalas, K.; Louizou, E.; Papoulidis, I.; Thomaidis, L.; Peitsidis, P.; Sotiriou, S.; Kitsos, G.; et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2, 26. [CrossRef] 39. Lynch, S.A.; Foulds, N.; Thuresson, A.C.; Collins, A.L.; Anner\u00e9n, G.; Hedberg, B.O.; Delaney, C.A.; Iremonger, J.; Murray, C.M.; Crolla, J.A.; et al. The 12q14 microdeletion syndrome: Six new cases con\ufb01rming the role of HMGA2 in growth. Eur. J. Hum. Genet. 2011, 19, 534\u2013539. [CrossRef] 31 of 33 Entropy 2023, 25, 897 40. Bartholdi, D.; Stray-Pedersen, A.; Azzarello-Burri, S.; Kibaek, M.; Kirchhoff, M.; Oneda, B.; R\u00f8dningen, O.; Schmitt-Mechelke, T.; Rauch, A.; Kjaergaard, S. A newly recognized 13q12.3 microdeletion syndrome characterized by intellectual disability, microcephaly, and eczema/atopic dermatitis encompassing the HMGB1 and KATNAL1 genes. Am. J. Med. Genet. Part A 2014, 164, 1277\u20131283. [CrossRef] 41. T\u00fcys\u00fcz, B.; Collin, A.; Arapo \u02d8glu, M.; Suyug\u00fcl, N. Clinical variability of Waardenburg\u2013Shah syndrome in patients with proximal 13q deletion syndrome including the endothelin-B receptor locus. Am. J. Med. Genet. Part A 2009, 149, 2290\u20132295. [CrossRef] Fonseca, D.J.; Prada, C.F.; Siza, L.M.; Angel, D.; Gomez, Y.M.; Restrepo, C.M.; Douben, H.; Rivadeneira, F.; de Klein, A.; Laissue, P. A de novo 14q12q13.3 interstitial deletion in a patient affected by a severe neurodevelopmental disorder of unknown origin. Am. J. Med. Genet. Part A 2012, 158, 689\u2013693. [CrossRef] 42. 43. Mart\u00ednez-Fern\u00e1ndez, M.L.; Bermejo-S\u00e1nchez, E.; Fern\u00e1ndez, B.; MacDonald, A.; Fern\u00e1ndez-Toral, J.; Mart\u00ednez-Fr\u00edas, M.L. Haploinsuf\ufb01ciency of BMP4 gene may be the underlying cause of Frias syndrome. Am. J. Med. Genet. Part A 2014, 164, 338\u2013345. [CrossRef] 44. Huang, H.; Mikami, Y.; Shigematsu, K.; Uemura, N.; Shinsaka, M.; Iwatani, A.; Miyake, F.; Kabe, K.; Takai, Y.; Saitoh, M.; et al. Kagami\u2013Ogata syndrome in a fetus presenting with polyhydramnios, malformations, and preterm delivery: A case report. J. Med. Case Rep. 2019, 13, 340. [CrossRef] 45. Murthy, S.; Nygren, A.; El Shakankiry, H.; Schouten, J.; Al Khayat, A.; Ridha, A.; Al Ali, M. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet. Genome Res. 2007, 116, 135\u2013140. [CrossRef] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 46. Mei, C.; Fedorenko, E.; Amor, D.J.; Boys, A.; Hoe\ufb02in, C.; Carew, P.; Burgess, T.; Fisher, S.E.; Morgan, A.T. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018, 26, 676\u2013686 [CrossRef] [PubMed] 47. Demopoulos, C.; Kothare, H.; Mizuiri, D.; Henderson-Sabes, J.; Fregeau, B.; Tjernagel, J.; Houde, J.F.; Sherr, E.H.; Nagarajan, S.S. Abnormal speech motor control in individuals with 16p11.2 deletions. Sci. Rep. 2018, 8, 1274. [CrossRef] [PubMed] Sahoo, T.; Theisen, A.; Rosenfeld, J.A.; Lamb, A.N.; Ravnan, J.B.; Schultz, R.A.; Torchia, B.S.; Neill, N.; Casci, I.; Bejjani, B.A.; et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet. Med. 2011, 13, 868\u2013880. [CrossRef] [PubMed] 49. Hennekam, R.C.; Baselier, A.C.; Beyaert, E.; Bos, A.; Blok, J.; Jansma, H.; Thorbecke-Nilsen, V.; Veerman, H. Psychological and speech studies in Rubinstein-Taybi syndrome. Am. J. Ment. Retard. 1992, 96, 645\u2013660. [PubMed] 50. Novara, F.; Rinaldi, B.; Sisodiya, S.M.; Coppola, A.; Giglio, S.; Stanzial, F.; Benedicenti, F.; Donaldson, A.; Andrieux, J.; Stapleton, R.; et al. Haploinsuf\ufb01ciency for ANKRD11-\ufb02anking genes makes"}